Avita Medical Inc. (ASX:AVH) has disclosed the issue of 267,533 shares of common stock (ASX security code: AVHAY) on 12 November 2026, following the cashless exercise of two separate warrant certificates by lenders Perceptive Credit Holdings V, LP and OrbiMed Royalty & Credit Opportunities IV, LP and OrbiMed Royalty & Credit Opportunities IV Offshore, LP.

Key Points

  • 267,533 shares of AVHAY common stock were issued on 12 November 2026 following two warrant exercises.
  • Perceptive Credit Holdings V, LP exercised a warrant for up to 150,000 shares via cashless exercise; 30,625 shares were withheld for the exercise price and 119,375 shares were issued.
  • OrbiMed exercised a warrant for up to 409,661 shares via cashless exercise; 261,503 shares were withheld for the exercise price and 148,158 shares were issued.
  • The newly issued shares rank equally in all respects with existing issued securities in the same class from their issue date.

Perceptive Warrant Exercise Details

Perceptive Credit Holdings V, LP exercised a warrant certificate issued by Avita Medical on 5 June 2026. According to the filing, that warrant was issued pursuant to a Credit Agreement and Guaranty dated 13 January 2026 between Perceptive and the company, and was exercisable for up to 150,000 shares of common stock in the event that the company borrowed additional funds under the Credit Agreement. The company borrowed those funds on 4 November 2026. Perceptive completed the exercise on a cashless basis, with the company withholding 30,625 shares in respect of the exercise price and issuing the remaining 119,375 shares to Perceptive on 12 November 2026.

OrbiMed Warrant Exercise Details

OrbiMed Royalty & Credit Opportunities IV, LP and OrbiMed Royalty & Credit Opportunities IV Offshore, LP collectively exercised a warrant certificate originally issued by Avita Medical on 18 October 2023. The filing states that warrant was issued pursuant to a Credit Agreement dated 18 October 2023 between an OrbiMed affiliate and the company, and was exercisable for up to 409,661 shares of common stock. OrbiMed also completed the exercise on a cashless basis, with the company withholding 261,503 shares in respect of the exercise price and issuing the remaining 148,158 shares to OrbiMed on 12 November 2026.

Securities Classification and Notification Date

The filing, lodged on 14 November 2026, is an Appendix 3G notification covering the conversion of unquoted warrants (ASX security code: AVHAAZ) into common stock (ASX security code: AVHAY). The securities issued are classified as an existing class and are not, and are not intended to be, quoted by ASX. The filing confirms the newly issued common stock ranks equally in all respects from its issue date with the existing issued securities in that class. Avita Medical Inc. is registered under ARBN 641288155.